The roots of Platycodon grandiflorum A. DC. (Campanulaceae), which are called Jiegeng in Chinese, are widely used in traditional Chinese medicine for the treatment of cough, excessive phlegm, chest congestion, pyocutaneous disease (suppurative disease), sore throat, upper respiratory tract infections, and tonsillitis. 1, 2) Previous chemical and pharmacological studies revealed that triterpenoid saponins are the primary components in P. grandiflorum, 3, 4) and these saponins have been reported to have significant biological activities such as antitumor, antimicrobial, and anti-inflammatory activities. [5] [6] [7] [8] With the aim of identifying new anti-tumor agents from this plant, we examined its ethanol extract. In this paper, we describe the isolation and characterization of two new triterpenoid saponins, platycodon A (1) and platycodon B (2) from Platycodon grandiflorum (Fig. 1) , and their in vitro cytotoxic activities against HepG-2, A549 and DU145 human cancer cell lines using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay method. C-NMR spectra suggested that compound 1 was an oleanolic triterpenoid saponin derivative. In conjunction with analysis of the heteronuclear multiple quantum coherence (HMQC) spectrum, Fig. 2 . Compared with the NMR data of the compounds reported previously, the aglycon of compound 1 was the same as Platycogenic acid C. 9, 10) In the nuclear Overhauser effect spectrosocpy (NOESY) spectrum, the β configuration of the hydroxyl group at H-21 was identified from the correlations as follows: H-21 (δ 3.42) with H-29 (δ 1.21); β configuration of the hydroxyl group at C-16 was identified from the correlation between H-16 (δ 4.34) and H-27 (δ 1.26). Therefore, the aglycon of 1 was established as 2β,3β,16 β,21β-tetrahydroxyolean-12-ene-28-oic acid.
11)
From the residual of acid hydrolysis, glucose was determined by means of TLC analysis and the absolute configuration was identified as D type compared with authentic monosaccharide by GC. The β configurations of the two d-glucoses were determined by their coupling constants ( Compounds 1 and 2 were tested for their in vitro cytotoxic activities against human hepatocellular carcinoma (HepG-2), human lung cancer (A549) and human prostatic cancer (DU145) cell lines. The results (Table 2) indicate that compounds 1 and 2 showed remarkable cytotoxic activities against HepG-2 and A549 cancer cell lines with IC 50 values ranging from 4.9 to 9.4 µm, but displayed weak cytotoxic activities against DU145 cancer cell line with IC 50 values greater than 10 µm. It should be noted that the significant cytotoxic activities of compounds 1 and 2 against HepG-2 and A549 may be due to their free carboxylic group at C-28. 12) Early studies on the cytotoxicity of similar compounds against several human cancer cell lines have reached the same results. 13, 14) Experimental General Experimental Procedures Optical rotations were determined on a Perkin-Elmer 341 digital polarimeter. IR spectra were obtained on a Shimadzu FTIR-8400S infrared spectrometer with KBr pellets. ESI-MS/MS and HR-ESI-MS were recorded on a LTQ Orbitrap XL mass spectrometer (Thermo Scientific, Boston, U.S.A.). 1D-and 2D-NMR were recorded with a 600 MHz NMR spectrometer (Varian NMR System). AB-8 macroporous resin produced by Nankai Chemical Industry was used. Silica gel (100-200, 200-300 mesh) for column chromatography, silica gel H for medium pressure liquid chromatography (MPLC), and silica gel PF254 for TLC were produced by Qingdao Marine Chemistry Ltd., People's Republic of China. Semi-preparative HPLC was performed on a LUMTECH instrument with a UV detector at 210 nm and using a C 30 column (Develosil Packed ϕ20×100 mm, Nomura Chemistry Ltd., Japan). The GC was carried out on an Agilent 7890A Gas chromatograph (Agilent Technology) with DB-1701 (30 m×0.25 mm, i.d.) (J&W) with a hydrogen flame ionization detector (FID) detector. The carrier gas was N 2 . The initial temperature was set at 80°C for 5 min and then increased to 270°C at a speed of 10°C/min.
Sample Collection The roots of Platycodon grandiflorum A. DC were collected at the Institute of Medical Plant Development and authenticated by Dr. Jianhe Wei (Institute of Medicinal Plant Development). A voucher specimen (P- has been deposited at the Herbarium of the Institute of Medicinal Plant Development, Beijing, People's Republic of China.
Extraction and Isolation The powder of the roots (4.0 kg) was refluxed with 95% ethanol three times. The ethanol extract was then concentrated in vacuum at 60°C to obtain a residue (0.9 kg). The residue was suspended in water and then partitioned with EtOAc. The aqueous layer was chromatographed over a macroporous resin AB-8 column eluted with H 2 O and then 95% EtOH. The 95% EtOH fraction was evaporated in vacuo to obtain the residue (213 g). The residue was chromatographed on a silica gel column (solvent, C-NMR data: see Table 1 . Acid Hydrolysis of 1 and 2 Each compound (2 mg) was heated in 3 mol/L CF 3 COOH (4 mL) for 3 h in a water bath. Each mixture was then extracted with EtOAc. The aqueous layer was evaporated to dryness with ethanol in vacuo at 50°C until neutral. The residues were determined in comparison with authentic monosaccharides using TLC (CHCl 3 : MeOH : H 2 O= 3 : 2:0.2, visualization with ethanol-5% H 2 SO 4 spraying). There was only glucose (Rf=0.25) in compound 1 and glucose (Rf=0.25) and xylose (Rf=0.37) in compound 2. Furthermore, the absolute configurations of the sugars were determined by gas chromatography according to a method previously described. 9, 15) In this method, l-cysteine methyl ester hydrochloride (0.06 mol/L) and hexamethyldisilazane-trimethylchlorosilane (HMDS-TMCS, 3 : 1) were added to the aqueous residue for derivatization. The solution was then centrifuged and the precipitate was removed. After these processes, n-hexane was used to extract derivate and analyzed by GC. d-Glucose (t R =26.3 min) and d-xylose (t R =17.3 min) were detected by comparing with authentic monosaccharides.
Cytotoxicity Assay The cytotoxicity of compounds 1 and 2 was assessed by the MTT method using HepG-2, A549 and DU145 cancer cell lines. Cells were grown in Dulbecco's modified Eagle's medium (DMEM) medium supplied with 10% fetal bovine serum and cultured at a density of 6× 10 4 cells/mL per well in a 96-well microtiter plate. Then 5 different concentrations of each compound dissolved in dimethyl sulfoxide (DMSO) were added to each well and compared to doxorubicin (Sigma, ≥98%) as the positive control. Each concentration was tested in triplicate. After incubation at 37°C in 5% CO 2 for 48 h, 10 µL of MTT (4 mg/mL) was added to each well and then the cells incubated for another 4 h. Next, the liquid in the well was removed and DMSO (200 µL) added to each well. The absorbance was recorded on a microplate reader at a wavelength of 570 nm. 
